Loading...

Leslie Wilson, PhD

TitleProfessor
SchoolUCSF School of Pharmacy
DepartmentClinical Pharmacy
Address3333 California Street
San Francisco CA 94118
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    Dr. Leslie Wilson is a Professor in the Department of Medicine and the Department of Clinical Pharmacy, School of Pharmacy at the University of California, San Francisco. Prior to joining the faculty at UCSF, she was the Director of Health Economics for Miles Inc. and also for Bayer AG. Dr. Wilson received her Ph.D. in health policy and economics from the University of Maryland. Her current research focuses on economic and outcome analyses including the cost of illness and cost effectiveness analyses of cancer and specific chronic diseases (including rare diseases) and how new diagnostics, treatments, and patterns of care affect the costs and outcomes of these diseases. She also looks at the epidemiology, risks and economics of Valley Fever, and also Chagas disease and its treatment in developing countries and in the U.S. blood supply. She also looks patient preference and decision making; specifically how patients weigh risks and benefits when making on treatment choices. Dr. Wilson is working with the FDA to help incorporate patient preference into approval of devices. In addition, Dr. Wilson studies the economics of policy issues, including the effects of drug legislation within the California Workers’ Compensation System, and cultural competence in California medical, dental and pharmacy schools. Dr. Wilson was instrumental in bringing health economics into the current and new pharmacy curriculum and teaches a course on decision analysis modeling and an elective and independent study on research in health economics. She is the developer and Co-Director of the Program for Pharmaceutical Economics and Policy Studies(ProPEPS) whose purpose is to organize the development of economic and policy research, teaching , and funding within the Department of Clinical Pharmacy. She works with the Department of Urology on the economic issues in treatment of prostate cancer, with the Department of Neurology on a CMS innovation grant looking at new economic models of dementia care, and with the Osher Center on the economics of integrative medicine treatments.


    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Global Health

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Possin KL, Merrilees J, Bonasera SJ, Bernstein A, Chiong W, Lee K, Wilson L, Hooper SM, Dulaney S, Braley T, Laohavanich S, Feuer JE, Clark AM, Schaffer MW, Schenk AK, Heunis J, Ong P, Cook KM, Bowhay AD, Gearhart R, Chodos A, Naasan G, Bindman AB, Dohan D, Ritchie C, Miller BL. Development of an adaptive, personalized, and scalable dementia care program: Early findings from the Care Ecosystem. PLoS Med. 2017 Mar; 14(3):e1002260. PMID: 28323819.
      View in: PubMed
    2. Hampson LA, Allen IE, Gaither TW, Lin T, Ting J, Osterberg EC, Wilson L, Breyer BN. Patient-centered Treatment Decisions for Urethral Stricture: Conjoint Analysis Improves Surgical Decision-making. Urology. 2016 Sep 16. PMID: 27645527.
      View in: PubMed
    3. Ting J, Wilson L, Schwarzenberg SJ, Himes R, Barth B, Bellin MD, Durie PR, Fishman DS, Freedman SD, Gariepy CE, Giefer MJ, Gonska T, Husain SZ, Kumar S, Morinville VD, Lowe ME, Ooi CY, Pohl JF, Troendle D, Usatin D, Werlin SL, Wilschanski M, Heyman MB, Uc A. Direct Costs of Acute Recurrent and Chronic Pancreatitis in Children in the INSPPIRE Registry. J Pediatr Gastroenterol Nutr. 2016 Mar; 62(3):443-9. PMID: 26704866.
      View in: PubMed
    4. Ting J, Tien Ho P, Xiang P, Sugay A, Abdel-Sattar M, Wilson L. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States. Value Health. 2015 Sep; 18(6):774-82. PMID: 26409604.
      View in: PubMed
    5. Shih V, Ten Ham RM, Bui CT, Tran DN, Ting J, Wilson L. Targeted Therapies Compared to Dacarbazine for Treatment of BRAF(V600E) Metastatic Melanoma: A Cost-Effectiveness Analysis. J Skin Cancer. 2015; 2015:505302. PMID: 26171248; PMCID: PMC4478371.
    6. Li Y, Bare LA, Bender RA, Sninsky JJ, Wilson L, Devlin JJ, Waldman FM. Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma. Mol Diagn Ther. 2015 Jun; 19(3):169-77. PMID: 25926090; PMCID: PMC4469775.
    7. Zaid UB, Hawkins M, Wilson L, Ting J, Harris C, Alwaal A, Zhao LC, Morey AF, Breyer BN. The cost of surveillance after urethroplasty. Urology. 2015 May; 85(5):1195-9. PMID: 25819624; PMCID: PMC4513932 [Available on 05/01/16].
    8. Wilson L, Loucks A, Gipson G, Zhong L, Bui C, Miller E, Owen M, Pelletier D, Goodin D, Waubant E, McCulloch CE. Patient preferences for attributes of multiple sclerosis disease-modifying therapies: development and results of a ratings-based conjoint analysis. Int J MS Care. 2015 Mar-Apr; 17(2):74-82. PMID: 25892977; PMCID: PMC4399770.
    9. Christopoulos KA, Riley ED, Tulsky J, Carrico AW, Moskowitz JT, Wilson L, Coffin LS, Falahati V, Akerley J, Hilton JF. A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial. BMC Infect Dis. 2014; 14:718. PMID: 25551175; PMCID: PMC4323139.
    10. Wilson L, Loucks A, Bui C, Gipson G, Zhong L, Schwartzburg A, Crabtree E, Goodin D, Waubant E, McCulloch C. Patient centered decision making: use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices. J Neurol Sci. 2014 Sep 15; 344(1-2):80-7. PMID: 25037284.
      View in: PubMed
    11. Wilson L, Tang J, Zhong L, Balani G, Gipson G, Xiang P, Yu D, Srinivas S. New therapeutic options in metastatic castration-resistant prostate cancer: Can cost-effectiveness analysis help in treatment decisions? J Oncol Pharm Pract. 2014 Dec; 20(6):417-25. PMID: 24243919.
      View in: PubMed
    12. Broering JM, Paciorek A, Carroll PR, Wilson L, Litwin MS, Miaskowski C. Measurement equivalence using a mixed-mode approach to administer health-related quality of life instruments. Qual Life Res. 2014 Mar; 23(2):495-508. PMID: 23943258.
      View in: PubMed
    13. Zhong L, Pon V, Srinivas S, Nguyen N, Frear M, Kwon S, Gong C, Malmstrom R, Wilson L. Therapeutic options in docetaxel-refractory metastatic castration-resistant prostate cancer: a cost-effectiveness analysis. PLoS One. 2013; 8(5):e64275. PMID: 23717582; PMCID: PMC3661482.
    14. Belkora J, Stupar L, O'Donnell S, Loucks A, Moore D, Jupiter C, Johnson N, Wilson L. Decision support by telephone: randomized controlled trial in a rural community setting. Patient Educ Couns. 2012 Oct; 89(1):134-42. PMID: 22776761.
      View in: PubMed
    15. Wilson L, Pregenzer M, Basu R, Bertenthal D, Torres J, Asgari M, Chren MM. Fee comparisons of treatments for nonmelanoma skin cancer in a private practice academic setting. Dermatol Surg. 2012 Apr; 38(4):570-84. PMID: 22145798; PMCID: PMC3839857.
    16. Wilson L, Hensic L, Paoli CJ, Basu R, Christenson M, Moskowitz JT, Wara D. The effect of prophylaxis on pediatric HIV costs. AIDS Care. 2012; 24(1):108-18. PMID: 21780991; PMCID: PMC4201115.
    17. Wilson L, Basu R, Christenson M, Hensic L, Paoli C, Wara D, Moskowitz JT. Pediatric HIV costs across three treatment eras from 1986 to 2007. Pediatrics. 2010 Sep; 126(3):e541-9. PMID: 20696721.
      View in: PubMed
    18. Wilson L, Ramsey JM, Koplowicz YB, Valiente-Banuet L, Motter C, Bertozzi SM, Tobler LH. Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks. Am J Trop Med Hyg. 2008 Jul; 79(1):53-68. PMID: 18606764.
      View in: PubMed
    19. Gitlin M, Wilson L. Repackaged pharmaceuticals in the California workers' compensation system: from distribution and pricing options to physician and retail dispensing. Am J Ind Med. 2007 Apr; 50(4):303-15. PMID: 17370319.
      View in: PubMed
    20. Mehling WE, Jacobs B, Acree M, Wilson L, Bostrom A, West J, Acquah J, Burns B, Chapman J, Hecht FM. Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial. J Pain Symptom Manage. 2007 Mar; 33(3):258-66. PMID: 17349495.
      View in: PubMed
    21. Wilson L, Tesoro R, Elkin EP, Sadetsky N, Broering JM, Latini DM, DuChane J, Mody RR, Carroll PR. Cumulative cost pattern comparison of prostate cancer treatments. Cancer. 2007 Feb 1; 109(3):518-27. PMID: 17186528.
      View in: PubMed
    22. Moskowitz JT, Butensky E, Harmatz P, Vichinsky E, Heyman MB, Acree M, Wrubel J, Wilson L, Folkman S. Caregiving time in sickle cell disease: psychological effects in maternal caregivers. Pediatr Blood Cancer. 2007 Jan; 48(1):64-71. PMID: 16622841.
      View in: PubMed
    23. Wilson L, Strosberg AM, Barrio K. Cost-effectiveness of Chagas disease interventions in latin america and the Caribbean: Markov models. Am J Trop Med Hyg. 2005 Nov; 73(5):901-10. PMID: 16282301.
      View in: PubMed
    24. Wilson L, Gitlin M. New workers' compensation legislation: expected pharmaceutical cost savings. Am J Ind Med. 2005 Oct; 48(4):239-48. PMID: 16142746.
      View in: PubMed
    25. Wilson L, Moskowitz JT, Acree M, Heyman MB, Harmatz P, Ferrando SJ, Folkman S. The economic burden of home care for children with HIV and other chronic illnesses. Am J Public Health. 2005 Aug; 95(8):1445-52. PMID: 15985648; PMCID: PMC1449379.
    26. Heyman MB, Harmatz P, Acree M, Wilson L, Moskowitz JT, Ferrando S, Folkman S. Economic and psychologic costs for maternal caregivers of gastrostomy-dependent children. J Pediatr. 2004 Oct; 145(4):511-6. PMID: 15480377.
      View in: PubMed
    27. Wilson L, Lin E, Lalwani A. Cost-effectiveness of intraoperative facial nerve monitoring in middle ear or mastoid surgery. Laryngoscope. 2003 Oct; 113(10):1736-45. PMID: 14520099.
      View in: PubMed
    28. Reyes CM, Allen BA, Terdiman JP, Wilson L. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness. Cancer. 2002 Nov 1; 95(9):1848-56. PMID: 12404277.
      View in: PubMed
    29. Wilson L, Reyes CM, Stolpman M, Speckman J, Allen K, Beney J. The direct cost and incidence of systemic fungal infections. Value Health. 2002 Jan-Feb; 5(1):26-34. PMID: 11873380.
      View in: PubMed
    Leslie's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP